Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 9, 2004, Pages 1495-1501

  Belshaw, Nigel J ^a   Elliott, Giles O ^a   Williams, Elizabeth A ^d   Bradbum, David M ^c   Mills, Sarah J ^c   Mathers, John C ^b   Johnson, Ian T ^a  

^a INSTITUTE OF FOOD RESEARCH   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c WANSBECK GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BISULFITE; DNA;

ADENOMATOUS POLYP; ADULT; ARTICLE; CANCER GENETICS; CANCER SURGERY; CLINICAL ARTICLE; COLON BIOPSY; COLON CARCINOGENESIS; COLON MUCOSA; COLON SURGERY; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DNA DETERMINATION; DNA ISOLATION; EPIGENETICS; ESR1 GENE; EVIDENCE BASED MEDICINE; FECES; FEMALE; GENE; HPP1 GENE; HUMAN; HUMAN TISSUE; MALE; METHYLATION; MGMT GENE; MLH1 GENE; NUCLEOTIDE SEQUENCE; P16 INK4ALPHA GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; QUANTITATIVE GENETICS; RESTRICTION MAPPING; SYMPTOM; TUMOR SUPPRESSOR GENE; VOLUNTEER;

ADENOMATOUS POLYPS; ALLELES; BIOPSY; CASE-CONTROL STUDIES; COLECTOMY; COLONOSCOPY; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; FEASIBILITY STUDIES; FECES; FEMALE; GENES, TUMOR SUPPRESSOR; HUMANS; INTESTINAL MUCOSA; MALE; MASS SCREENING; MIDDLE AGED; POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 4444246516     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenomacarcinoma sequence. Br J Surg 2002;89:845-60.
2. Bodmer WF. 1998 Runme Shaw Memorial Lecture: somatic evolution of cancer. Ann Acad Med Singapore 1999;28:323-9.
3. Issa JP. The epigenetics of colorectal cancer. Ann NY Acad Sci 2000;910:140-53; discussion 153-5.
4. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumors. J Pathol 2002;196:1-7.
5. Feinberg AP. Cancer epigenetics takes center stage. Proc Natl Acad Sci U S A 2001;98:392-4.
6. Jubb AM, Bell SM, Quirke P. Methylation and colorectal cancer. J Pathol 2001;195:111-34.
7. Bestor TH. Gene silencing. Methylation meets acetylation. Nature 1998;393:311-2.
8. Furukawa T, Konishi F, Masubuchi S, Shitoh K, Nagai H, Tsukamoto T. Densely methylated MLH1 promoter correlates with decreased mRNA expression in sporadic colorectal cancers. Genes Chromosomes Cancer 2002;35:1-10.
9. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-6.
10. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 2002;160:529-36.
11. Esteller M, Sparks A, Toyota M, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000;60:4366-71.
12. Chan AO, Broaddus RR, Houlihan PS, Issa JP, Hamilton SR, Rashid A. CpG island methylation in aberrant crypt foci of the colorectum. Am J Pathol 2002;160:1823-30.
13. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the estrogen receptor CpG island links aging and neoplasia in human colon. Nat Genet 1994,7:536-40.
14. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res 2001;61:3225-9.
15. Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 2000;60:5954-8.
16. Ahlquist DA, Klatt KK, Harrington JJ, Cunningham JM, Man J, Shuber AP. Novel use of hypermethylated DNA markers in stool for detection of colorectal cancer: a feasibility study. Gasrroenterology 2002;122:A40;354.
17. Raizis AM, Schmitt F, Jost JP. A bisulfite method of 5-methylcytosine mapping that minimizes template degradation. Anal Biochem 1995;226:161-6.
18. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
19. Xiong Z, Laird PW. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res 1997;25:2532-4.
20. Nakayama H, Hibi K, Taguchi M, et al. Molecular detection of p16 promoter methylation in the serum of colorectal cancer patients. Cancer Lett 2002;188:115-9.
21. Hibi K, Taguchi M, Nakayama H, et al. Molecular detection of p16 promoter methylation in the serum of patients with esophageal squamous cell carcinoma. Clin Cancer Res 2001;7:3135-8.
22. Grady WM, Rajput A, Lutterbaugh JD, Markowitz SD. Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer. Cancer Res 2001;61:900-2.
23. Usadel H, Brabender J, Danenberg KD, et al. Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer. Cancer Res 2002;62:371-5.
24. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001;61:3573-7.
25. Young J, Biden KG, Simms LA, et al. HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A 2001;98:265-70.
26. Sato F, Shibata D, Harpaz N, et al. Aberrant methylation of the HPP1 gene in ulcerative colitis-associated colorectal carcinoma. Cancer Res 2002;62:6820-2.
27. Esteller M, Catasus L, Matias-Guiu X, et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999;155:1767-72.
28. Ueki T, Toyota M, Sohn T, et al. Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 2000;60:1835-9.
29. Fleisher AS, Esteller M, Harpaz N, et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res 2000;60:4864-8.
30. Nakagawa H, Nuovo GJ, Zervos EE, et al. Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development. Cancer Res 2001;61:6991-5.
31. Chen DL, Swe M, Sit KH. G-band expression and megabase fragmentations in apoptosis. Exp Cell Res 1998;240:293-304.
32. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci U S A 1998;95:6870-5.
33. Traverso G, Shuber A, Olsson L, et al. Detection of proximal colorectal cancers through analysis of fecal DNA. Lancet 2002;359:403-4.
34. Traverso G, Shuber A, Levin B, et al. Detection of APC mutations in fecal DNA from patients with colorectal tumors. N Engl J Med 2002;346:311-20.
35. Davies RJ, Freeman A, Morris LS, et al. Analysis of minichromosome maintenance proteins as a novel method for detection of colorectal cancer in stool. Lancet 2002;359:1917-9.
36. Cui H, Cruz-Correa M, Giardiello FM, et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003;299:1753-5.